Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiation-inducible gene therapy.

H J Mauceri1, N N Hanna, M J Staba

  • 1Department of Radiation and Cellular Oncology, University of Chicago, IL 60637, USA. rrw@rover.uchicago.edu

Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie
|April 10, 1999
PubMed
Summary

Gene therapy using Egr-TNF alpha in human xenografts inhibits tumor growth by targeting infected cells and tumor vasculature. Combining gene therapy with radiation shows promise for treating localized cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers.

Scientific reports·2016
Same author

Resuscitation at the limit of viability: trapped between a rock and a hard place.

Journal of neonatal-perinatal medicine·2013
Same author

MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches.

Oncogene·2012
Same author

Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2011
Same author

Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy.

Cancer gene therapy·2008
Same author

Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapy.

Cancer gene therapy·2007

Area of Science:

  • Oncology
  • Gene Therapy
  • Radiation Oncology

Background:

  • The Egr-TNF alpha genetic construct is radiation-inducible.
  • Tumor microvasculature is a target for cancer therapies.

Purpose of the Study:

  • To evaluate the efficacy of the Egr-TNF alpha genetic construct in combination with radiation therapy.
  • To assess the impact on tumor growth, cell cytotoxicity, and tumor microvasculature.

Main Methods:

  • Introduction of the radiation-inducible Egr-TNF alpha genetic construct into human xenografts.
  • Administration of radiation therapy in conjunction with the gene therapy.
  • Assessment of tumor cell cytotoxicity, tumor growth inhibition, and effects on tumor vasculature.

Main Results:

Related Experiment Videos

  • The Egr-TNF alpha construct induced cytotoxicity in infected tumor cells, leading to tumor growth inhibition.
  • The combination of Egr-TNF alpha and radiation demonstrated selective cytotoxicity towards tumor microvasculature.
  • Tumor vascular thrombosis and necrosis were observed as a result of the combined treatment.

Conclusions:

  • Gene therapy with Egr-TNF alpha, when combined with radiation therapy, effectively inhibits tumor growth.
  • This combined approach shows significant potential for the treatment of localized human cancers.
  • Targeting tumor microvasculature alongside tumor cells offers a promising therapeutic strategy.